US Stock MarketDetailed Quotes

VTYX Ventyx Biosciences

Watchlist
  • 1.200
  • -0.060-4.76%
Close Apr 25 16:00 ET
85.39MMarket Cap-0.61P/E (TTM)

About Ventyx Biosciences Company

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Company Profile

SymbolVTYX
Company NameVentyx Biosciences
Listing DateOct 21, 2021
Issue Price16.00
Founded2018
CEODr. Raju S. Mohan, PhD
MarketNASDAQ
Employees82
Fiscal Year Ends12-31
Address12790 El Camino Real,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-760-593-4832
Websitehttp://www.ventyxbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Raju S. Mohan, PhD
  • Director, Chief Executive Officer and President
  • 1.28M
  • Matthew Richard Moore
  • Chief Operating Officer
  • 1.92M
  • Dr. Mark S. Forman, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. John M. Nuss, PhD
  • Chief Scientific Officer
  • --
  • Roy M. Gonzales
  • Senior Vice President, Finance, Interim Principal Financial Officer and Interim Principal Accounting Officer
  • --
  • Dr. Allison J. Hulme, PhD
  • Director
  • 170.83K
  • Onaiza Cadoret-Manier
  • Independent Director
  • 173.83K
  • William R. White, J.D.
  • Independent Director
  • 172.33K
  • Somasundaram Subramaniam, M.B.A.
  • Independent Director
  • 174.33K
  • Dr. Sheila Gujrathi, M.D.
  • Executive Chairperson of the Board
  • 335.93K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Mawson Infrastructure
MIGI
0.6030
Abits
ABTS
3.220
Intchains Group
ICG
1.890
4
BTCS Inc
BTCS
1.910
5
Canaan
CAN
0.8330
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Earnings Season Underway

Earnings season is here. What to know?